Société Arabe Internationale de Banque S.A.E (EGX:SAIB)

Sage Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	417.43	616.98	734.68	692.66	616.36	387.23
Investment Securities	390.84	749.06	848.61	797.27	1,378	1,806
Total Investments	390.84	749.06	848.61	797.27	1,378	1,806
Gross Loans	1,478	1,341	1,527	1,689	2,167	1,771
Allowance for Loan Losses	-80.27	-76.74	-85.94	-83.33	-83.37	-66.42
Other Adjustments to Gross Loans	-6.54	-6.41	-6.36	-22.97	-17.72	-20.85
Net Loans	1,391	1,258	1,435	1,583	2,066	1,684
Property, Plant & Equipment	43.14	40.83	37.95	37.12	28.43	29.81
Other Intangible Assets	5.92	6.04	6.16	5.15	5.72	1.69
Accrued Interest Receivable	30.34	27.98	25.34	21.6	43.25	54.68
Other Receivables	649.73	30	40	70.21	55.45	73.77
Restricted Cash	217.25	171.29	308.58	243.67	305.82	289.34
Other Current Assets	6.72	4.39	5.59	2.37	3.92	6.05
Long-Term Deferred Tax Assets	-	-	-	-	0.31	0.06
Other Real Estate Owned & Foreclosed	25.5	25.44	26.42	17.03	17.03	0.33
Other Long-Term Assets	24.84	20.55	16.77	19.07	14.25	12.97
Total Assets	3,203	2,950	3,485	3,489	4,534	4,346
Accrued Expenses	3.77	3.67	6.02	6.66	4.72	15.04
Interest Bearing Deposits	2,519	2,308	2,727	2,721	3,744	3,510
Non-Interest Bearing Deposits	193.68	158.37	212.33	266.14	293.32	322.53
Total Deposits	2,712	2,466	2,940	2,987	4,037	3,833
Current Portion of Long-Term Debt	30	30	40	50	30	50
Current Portion of Leases	0.04	0.05	0.15	0.2	0.42	0.43
Current Income Taxes Payable	9.96	8.54	9.41	4.5	7.53	-
Accrued Interest Payable	16.97	14.92	22	20.46	23.95	23.1
Other Current Liabilities	19.86	1.66	5.03	6.19	11.96	8.73
Long-Term Debt	17.48	17.54	40.6	52.91	54.25	51.59
Long-Term Leases	0.03	0.05	0.15	0.39	0.8	0.88
Long-Term Unearned Revenue	1.6	1.56	1.91	1.79	2.86	2.55
Long-Term Deferred Tax Liabilities	0.73	0.81	0.45	0.04	-	-
Other Long-Term Liabilities	20.03	17.32	19.77	16.88	10.2	9.79
Total Liabilities	2,833	2,563	3,085	3,147	4,184	3,995
Common Stock	331.03	331.03	331.03	157.5	150	150
Retained Earnings	41.31	59.35	49.68	192.5	167.36	153.99
Comprehensive Income & Other	-2.19	-2.46	18.85	-7.59	33.13	46.82
Shareholders' Equity	370.15	387.92	399.56	342.4	350.49	350.81
Total Liabilities & Equity	3,203	2,950	3,485	3,489	4,534	4,346
Total Debt	47.55	47.64	80.9	103.5	85.46	102.9
Net Cash (Debt)	369.88	569.34	653.78	589.17	530.89	284.33
Net Cash Growth	-45.94%	-12.91%	10.97%	10.98%	86.72%	-25.23%
Net Cash Per Share	11.17	17.20	19.75	17.80	16.04	8.59
Filing Date Shares Outstanding	33.1	33.1	33.1	33.1	33.1	33.1
Total Common Shares Outstanding	33.1	33.1	33.1	33.1	33.1	33.1
Book Value Per Share	11.18	11.72	12.07	10.34	10.59	10.60
Tangible Book Value	364.23	381.88	393.4	337.25	344.77	349.12
Tangible Book Value Per Share	11.00	11.54	11.88	10.19	10.42	10.55

Updated Feb 17, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.